Regenerative therapies for central nervous system diseases: A biomaterials approach

Neuropsychopharmacology

Volumn 39, Issue 1, 2014, Pages 169-188

  Tam, Roger Y ^a,b   Fuehrmann, Tobias ^a,b   Mitrousis, Nikolaos ^b   Shoichet, Molly S ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

biomaterials; hydrogels; molecular and cellular neurobiology; neurodegeneration neuroprotection; neuropeptides; tissue engineering

Indexed keywords

BIOMATERIAL; BRAIN DERIVED NEUROTROPHIC FACTOR; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; CHONDROITIN ABC LYASE; CILIARY NEUROTROPHIC FACTOR; COLLAGEN; EPIDERMAL GROWTH FACTOR; ERYTHROPOIETIN; FIBRONECTIN; GELATINASE A; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HYALURONIC ACID; INTEGRIN RECEPTOR; KRUPPEL LIKE FACTOR 4; LAMININ; LEUKEMIA INHIBITORY FACTOR; NERVE CELL ADHESION MOLECULE; NERVE GROWTH FACTOR; NEUROCAN; NEUROFILAMENT 200 PROTEIN; NEUROFILAMENT PROTEIN; NEUROTROPHIN 3; NOGO A ANTIBODY; OCTAMER TRANSCRIPTION FACTOR 4; POLY(METHYL METHACRYLATE); PROTEOCHONDROITIN SULFATE; RECOVERIN; RHODOPSIN; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; HYDROGEL; NEUROPROTECTIVE AGENT;

BIOCOMPATIBILITY; BLOOD BRAIN BARRIER; CELL ADHESION; CELL AGGREGATION; CELL COMMUNICATION; CELL CONTACT; CELL DIFFERENTIATION; CELL FATE; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL SUSPENSION; CELL TRANSPLANTATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; CYTOARCHITECTURE; DRUG DELIVERY SYSTEM; EMBRYONIC STEM CELL; GLIOSIS; GRAFT SURVIVAL; HUMAN; HYDROGEL; INTRACELLULAR SIGNALING; MESENCHYMAL STROMA CELL; MINIPUMP; MULTIPOTENT STEM CELL; NERVE FIBER GROWTH; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; RETINA DEGENERATION; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; SUSTAINED DRUG RELEASE; TISSUE REGENERATION; TISSUE REPAIR; TUMOR MICROENVIRONMENT; VITREORETINOPATHY; ANIMAL; BIOLOGICAL THERAPY; CENTRAL NERVOUS SYSTEM DISEASES; NERVE DEGENERATION; PROCEDURES; THERAPEUTIC USE;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL- AND TISSUE-BASED THERAPY; CENTRAL NERVOUS SYSTEM DISEASES; DRUG DELIVERY SYSTEMS; HUMANS; HYDROGELS; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS;

EID: 84890443613     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.237     Document Type: Review

References (240)

1. Aizawa Y, Leipzig N, Zahir T, Shoichet M (2008). The effect of immobilized platelet derived growth factor AA on neural stem/progenitor cell differentiation on celladhesive hydrogels. Biomaterials 29: 4676-4683
2. Aizawa Y, Shoichet MS (2012). The role of endothelial cells in the retinal stem and progenitor cell niche within a 3D engineered hydrogel matrix. Biomaterials 33: 5198-5205
3. Aizawa Y, Wylie R, Shoichet M (2010). Endothelial cell guidance in 3D patterned scaffolds. Adv Mater 22: 4831.
4. Amon M, Menapace R (1994). In-vivo documentation of cellular reactions on lens surfaces for assessing the biocompatibility of different intraocular implants. Eye 8: 649-656
5. Azagarsamy MA, Anseth KS (2013). Bioorthogonal click chemistry: An indispensable tool to create multifaceted cell culture scaffolds. ACS Macro Lett 2: 5-9
6. Ballios BG, Cooke MJ, van der Kooy D, Shoichet MS (2010). A hydrogel-based stem cell delivery system to treat retinal degenerative diseases. Biomaterials 31: 2555-2564
7. Bang OY, Lee JS, Lee PH, Lee G (2005). Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 57: 874-882
8. Becker AJ, Mc CE, Till JE (1963). Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 197: 452-454
9. Beer JH, Springer KT, Coller BS (1992). Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor. Blood 79: 117-128
10. Belverud S, Mogilner A, Schulder M (2008). Intrathecal pumps. Neurotherapeutics 5: 114-122
11. Bhatt NS, Newsome DA, Fenech T, Hessburg TP, Diamond JG, Miceli MV et al. (1994). Experimental transplantation of human retinal-pigment epithelial-cells on collagen substrates. Am J Ophthalmol 117: 214-221
12. Bible E, Qutachi O, Chau DY, Alexander MR, Shakesheff KM, Modo M (2012). Neovascularization of the stroke cavity by implantation of human neural stem cells on VEGF-releasing PLGA microparticles. Biomaterials 33: 7435-7446
13. Bliss TM, Andres RH, Steinberg GK (2010). Optimizing the success of cell transplantation therapy for stroke. Neurobiol Disease 37: 275-283
14. Bockelmann J, Klinkhammer K, von Holst A, Seiler N, Faissner A, Brook GA et al. (2011). Functionalization of electrospun poly(epsilon-caprolactone) fibers with the extracellular matrix-derived peptide GRGDS improves guidance of schwann cell migration and axonal growth. Tissue Eng A 17: 475-486
15. Bongso A, Richards M (2004). History and perspective of stem cell research. Best Pract Res Clin Obstet Gynaecol 18: 827-842
16. Bozkurt A, Deumens R, Beckmann C, Olde Damink L, Schugner F, Heschel I et al. (2009). In vitro cell alignment obtained with a Schwann cell enriched microstructured nerve guide with longitudinal guidance channels. Biomaterials 30: 169-179
17. Bradbury EJ, McMahon SB (2006). Opinion-Spinal cord repair strategies: Why do they work? Nat Rev Neurosci 7: 644-653
18. Bruns TJ, Hauser WA (2003). The epidemiology of traumatic brain injury: A review. Epilepsia 44: 2-10
19. Bunge MB, Pearse DD (2003). Transplantation strategies to promote repair of the injured spinal cord. J Rehabil Res Dev 40: 55-62
20. Caicco MJ, Cooke MJ, Wang Y, Tuladhar A, Morshead CM, Shoichet MS (2013a). A hydrogel composite system for sustained epi-cortical delivery of Cyclosporin A to the brain for treatment of stroke. J Control Release 166: 197-202
21. Caicco MJ, Zahir T, Mothe AJ, Ballios BG, Kihm AJ, Tator CH et al. (2013b). Characterization of hyaluronan-methylcellulose hydrogels for cell delivery to the injured spinal cord. J Biomed Mater Res A 101: 1472-1477
22. Chaitin MH, Brun-Zinkernagel AM (1998). Immunolocalization of CD44 in the dystrophic rat retina. Exp Eye Res 67: 283-292
23. Chan CC (2008). Inflammation: Beneficial or detrimental after spinal cord injury? Recent Pat CNS Drug Discov 3: 189-199
24. Chen CS, Mrksich M, Huang S, Whitesides GM, Ingber DE (1997). Geometric control of cell life and death. Science 276: 1425-1428
25. Chen CS, Mrksich M, Huang S, Whitesides GM, Ingber DE (1998). Micropatterned surfaces for control of cell shape, position, and function. Biotechnol Prog 14: 356-363
26. Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA et al. (2000). Nogo-A is a myelin-Associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403: 434-439
27. Cheng TY, Chen MH, Chang WH, Huang MY, Wang TW (2013). Neural stem cells encapsulated in a functionalized self-Assembling peptide hydrogel for brain tissue engineering. Biomaterials 34: 2005-2016
28. Cheung CY, Anseth KS (2006). Synthesis of immunoisolation barriers that provide localized immunosuppression for encapsulated pancreatic islets. Bioconjug Chem 17: 1036-1042
29. Citron M (2010). Alzheimer's disease: Strategies for disease modification. Nat Rev Drug Discov 9: 387-398
30. Clarke L, van der Kooy D (2011). The adult mouse dentate gyrus contains populations of committed progenitor cells that are distinct from subependymal zone neural stem cells. Stem Cells 29: 1448-1458
31. Comoglio PM, Boccaccio C, Trusolino L (2003). Interactions between growth factor receptors and adhesion molecules: Breaking the rules. Curr Opin Cell Biol 15: 565-571
32. Conova L, Vernengo J, Jin Y, Himes BT, Neuhuber B, Fischer I et al. (2011). A pilot study of poly(N-isopropylacrylamide)-g-polyethylene glycol and poly(N-isopropylacrylamide)-g-methylcellulose branched copolymers as injectable scaffolds for local delivery of neurotrophins and cellular transplants into the injured spinal cord. J Neurosurg Spine 15: 594-604
33. Cooke MJ, Vulic K, Shoichet MS (2010). Design of biomaterials to enhance stem cell survival when transplanted into the damaged central nervous system. Soft Matter 6: 4988-4998
34. Cooke MJ, Wang YF, Morshead CM, Shoichet MS (2011). Controlled epi-cortical delivery of epidermal growth factor for the stimulation of endogenous neural stem cell proliferation in stroke-injured brain. Biomaterials 32: 5688-5697
35. Craig WS, Cheng S, Mullen DG, Blevitt J, Pierschbacher MD (1995). Concept and progress in the development of RGD-containing peptide pharmaceuticals. Biopolymers 37: 157-175
36. Davie CA (2008). A review of Parkinson's disease. Brit Med Bull 86: 109-127
37. Davies JE, Huang C, Proschel C, Noble M, Mayer-Proschel M, Davies SJ (2006). Astrocytes derived from glial-restricted precursors promote spinal cord repair. J Biol 5: 7
38. de Jong PT (2006). Age-related macular degeneration. N Engl JMed 355: 1474-1485
39. de Las Heras Alarcon C, Pennadam S, Alexander C (2005). Stimuli responsive polymers for biomedical applications. Chem Soc Rev 34: 276-285
40. DeForest CA, Anseth KS (2011). Cytocompatible click-based hydrogels with dynamically tunable properties through orthogonal photoconjugation and photocleavage reactions. Nat Chem 3: 925-931
41. DeQuach JA, Yuan SH, Goldstein LSB, Christman KL (2011). Decellularized porcine brain matrix for cell culture and tissue engineering scaffolds. Tissue Eng Pt A 17: 2583-2592
42. DeVore DP (1991). Long-Term compatibility of intraocular lens implant materials. J Long Term Eff Med Implants 1: 205-216
43. Dibajnia P, Morshead CM (2013). Role of neural precursor cells in promoting repair following stroke. Acta Pharmacol Sin 34: 78-90
44. Domeniconi M, Cao Z, Spencer T, Sivasankaran R, Wang K, Nikulina E et al. (2002). Myelin-Associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 35: 283-290
45. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317
46. Drury JL, Mooney DJ (2003). Hydrogels for tissue engineering: Scaffold design variables and applications. Biomaterials 24: 4337-4351
47. Emerich DF, Silva E, Ali O, Mooney D, Bell W, Yu SJ et al. (2010). Injectable VEGF hydrogels produce near complete neurological and anatomical protection following cerebral ischemia in rats. Cell Transplant 19: 1063-1071
48. Engler AJ, Sen S, Sweeney HL, Discher DE (2006). Matrix elasticity directs stem cell lineage specification. Cell 126: 677-689
49. Erlandsson A, Lin CHA, Yu FG, Morshead CM (2011). Immunosuppression promotes endogenous neural stem and progenitor cell migration and tissue regeneration after ischemic injury. Experimen Neurol 230: 48-57
50. Evans MJ, Kaufman MH (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154-156
51. Fitch MT, Silver J (2008). CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp Neurol 209: 294-301
52. Flemming RG, Murphy CJ, Abrams GA, Goodman SL, Nealey PF (1999). Effects of synthetic micro-And nano-structured surfaces on cell behavior. Biomaterials 20: 573-588
53. Fortun J, Hill CE, Bunge MB (2009). Combinatorial strategies with Schwann cell transplantation to improve repair of the injured spinal cord. Neurosci Lett 456: 124-132
54. Freier T, Montenegro R, Shan Koh H, Shoichet MS (2005). Chitin-based tubes for tissue engineering in the nervous system. Biomaterials 26: 4624-4632
55. Freund P, Schmidlin E, Wannier T, Bloch J, Mir A, Schwab ME et al. (2006). Nogo-A-specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates. Nat Med 12: 790-792
56. Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970). The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3: 393-403
57. Garcia-Alias G, Barkhuysen S, Buckle M, Fawcett JW (2009). Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation. Nat Neurosci 12: 1145-1151
58. Ghirnikar RS, Lee YL, Eng LF (2000). Chemokine antagonist infusion attenuates cellular infiltration following spinal cord contusion injury in rat. J Neurosci Res 59: 63-73
59. Ghosh F, Rauer O, Arner K (2008). Neuroretinal xenotransplantation to immunocompetent hosts in a discordant species combination. Neuroscience 152: 526-533
60. Giordano GG, Chevezbarrios P, Refojo MF, Garcia CA (1995). Biodegradation and tissue reaction to intravitreous biodegradable Poly(D,L-lactic-co-glycolic) acid microspheres. Curr Eye Res 14: 761-768
61. Goldsmith HS, de la Torre JC (1992). Axonal regeneration after spinal cord transection and reconstruction. Brain Res 589: 217-224
62. Gouras P, Flood MT, Kjeldbye H (1984). Transplantation of cultured human retinal cells to monkey retina. An Acad Bras Cienc 56: 431-443
63. Gouras P, Flood MT, Kjeldbye H, Bilek MK, Eggers H (1985). Transplantation of cultured human retinal epithelium to bruchs membrane of the owl monkeys eye. Curr Eye Res 4: 253-265
64. Graf J, Ogle RC, Robey FA, Sasaki M, Martin GR, Yamada Y et al. (1987). A pentapeptide from the laminin-B1 chain mediates cell-Adhesion and binds the 67000-laminin receptor. Biochemistry 26: 6896-6900
65. Grant RP, Spitzfaden C, Altroff H, Campbell ID, Mardon HJ (1997). Structural requirements for biological activity of the ninth and tenth FIII domains of human fibronectin. J Biol Chem 272: 6159-6166
66. Groothuis DR (2000). The blood-brain and blood-Tumor barriers: A review of strategies for increasing drug delivery. Neuro-Oncology 2: 45-59
67. Guo J, Su H, Zeng Y, Liang YX, Wong WM, Ellis-Behnke RG et al. (2007). Reknitting the injured spinal cord by self-Assembling peptide nanofiber scaffold. Nanomed Nanotechnol Biol Med 3: 311-321
68. Gupta D, Tator CH, Shoichet MS (2006). Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials 27: 2370-2379
69. Han LH, Lai JH, Yu S, Yang F (2013). Dynamic tissue engineering scaffolds with stimuli-responsive macroporosity formation. Biomaterials 34: 4251-4258
70. Hauben E, Butovsky O, Nevo U, Yoles E, Moalem G, Agranov E et al. (2000). Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci 20: 6421-6430
71. Haubner R, Gratias R, Diefenbach B, Goodman SL, Jonczyk A, Kessler H (1996). Structural and functional aspects of RGD-containing cyclic pentapeptides as highly potent and selective integrin alpha(v)beta(3) antagonists. J Am Chem Soc 118: 7461-7472
72. Hawryluk GW, Rowland J, Kwon BK, Fehlings MG (2008). Protection and repair of the injured spinal cord: A review of completed, ongoing, and planned clinical trials for acute spinal cord injury. Neurosurg Focus 25: E14
73. Hejcl A, Sedy J, Kapcalova M, Toro DA, Amemori T, Lesny P et al. (2010). HPMA-RGD hydrogels seeded with mesenchymal stem cells improve functional outcome in chronic spinal cord injury. Stem Cells Dev 19: 1535-1546
74. Hersel U, Dahmen C, Kessler H (2003). RGD modified polymers: Biomaterials for stimulated cell adhesion and beyond. Biomaterials 24: 4385-4415
75. Hoare TR, Kohane DS (2008). Hydrogels in drug delivery: Progress and challenges. Polymer 49: 1993-2007
76. Hoffman-Kim D, Mitchel JA, Bellamkonda RV (2010). Topography, cell response, and nerve regeneration. Annu Rev Biomed Eng 12: 203-231
77. Hofstetter CP, Holmstrom NAV, Lilja JA, Schweinhardt P, Hao JX, Spenger C et al. (2005). Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci 8: 346-353
78. Hofstetter CP, Schwarz EJ, Hess D, Widenfalk J, El Manira A, Prockop DJ et al. (2002). Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci USA 99: 2199-2204
79. Hsiue GH, Lai JY, Lin PK (2002). Absorbable sandwich-like membrane for retinalsheet transplantation. J Biomed Mater Res 61: 19-25
80. Hyatt AJ, Wang D, Kwok JC, Fawcett JW, Martin KR (2010). Controlled release of chondroitinase ABC from fibrin gel reduces the level of inhibitory glycosaminoglycan chains in lesioned spinal cord. J Control Release 147: 24-29
81. Inatani M, Tanihara H, Oohira A, Honjo M, Kido N, Honda Y (2000). Upregulated expression of neurocan, a nervous tissue specific proteoglycan, in transient retinal ischemia. Invest Ophth Vis Sci 41: 2748-2754
82. Itosaka H, Kuroda S, Shichinohe H, Yasuda H, Yano S, Kamei S et al. (2009). Fibrin matrix provides a suitable scaffold for bone marrow stromal cells transplanted into injured spinal cord: A novel material for CNS tissue engineering. Neuropathology 29: 248-257
83. Jain A, Kim YT, McKeon RJ, Bellamkonda RV (2006). In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury. Biomaterials 27: 497-504
84. Jiang D, Liang J, Noble PW (2007). Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Bi 23: 435-461
85. Jimenez Hamann MC, Tator CH, Shoichet MS (2005). Injectable intrathecal delivery system for localized administration of EGF and FGF-2 to the injured rat spinal cord. Exp Neurol 194: 106-119
86. Johnson PJ, Tatara A, McCreedy DA, Shiu A, Sakiyama-Elbert SE (2010a). Tissueengineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI. Soft Matter 6: 5127-5137
87. Johnson PJ, Tatara A, Shiu A, Sakiyama-Elbert SE (2010b). Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI. Cell Transplant 19: 89-101
88. Kang YM, Hwang DH, Kim BG, Go DH, Park KD (2010). Thermosensitive polymerbased hydrogel mixed with the anti-inflammatory agent minocycline induces axonal regeneration in hemisected spinal cord. Macromol Res 18: 399-403
89. Kato M, Mrksich M (2004). Using model substrates to study the dependence of focal adhesion formation on the affinity of integrin-ligand complexes. Biochemistry 43: 2699-2707
90. Kauer TM, Figueiredo JL, Hingtgen S, Shah K (2012). Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas. Nat Neurosci 15: 197-204
91. Kelley MW, Turner JK, Reh TA (1995). Regulation of proliferation and photoreceptor differentiation in fetal human retinal cell cultures. Invest Ophthalmol Vis Sci 36: 1280-1289
92. Kim H, Zahir T, Tator CH, Shoichet MS (2011a). Effects of dibutyryl cyclic-Amp on survival and neuronal differentiation of neural stem/progenitor cells transplanted into spinal cord injured rats. PLoS ONE 6: E21744
93. Kim SH, Turnbull J, Guimond S (2011b). Extracellular matrix and cell signalling: The dynamic cooperation of integrin, proteoglycan and growth factor receptor. J Endocrinol 209: 139-151
94. Kim YT, Caldwell JM, Bellamkonda RV (2009). Nanoparticle-mediated local delivery of methylprednisolone after spinal cord injury. Biomaterials 30: 2582-2590
95. Klassen H, Schwartz MR, Bailey AH, Young MJ (2001). Surface markers expressed by multipotent human and mouse neural progenitor cells include tetraspanins and non-protein epitopes. Neurosci Lett 312: 180-182
96. Kleinman HK, Martin GR (2005). Matrigel: Basement membrane matrix with biological activity. Semin Cancer Biol 15: 378-386
97. Kode JA, Mukherjee S, Joglekar MV, Hardikar AA (2009). Mesenchymal stem cells: Immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 11: 377-391
98. Kokaia Z, Martino G, Schwartz M, Lindvall O (2012). Cross-Talk between neural stem cells and immune cells: The key to better brain repair? Nat Neurosci 15: 1078-1087
99. Kolb B, Morshead C, Gonzalez C, Kim M, Gregg C, Shingo T et al. (2007). Growth factor-stimulated generation of new cortical tissue and functional recovery after stroke damage to the motor cortex of rats. J Cerebr Blood F Met 27: 983-997
100. Kondziolka D, Steinberg GK, Wechsler L, Meltzer CC, Elder E, Gebel J et al. (2005). Neurotransplantation for patients with subcortical motor stroke: A Phase 2 randomized trial. J Neurosurg 103: 38-45
101. Krishnamoorthy R, Agarwal N, Chaitin MH (2000). Upregulation of CD44 expression in the retina during the RDS degeneration. Brain Res Mol Brain Res 77: 125-130
102. Kwon BK, Tetzlaff W, Grauer JN, Beiner J, Vaccaro AR (2004). Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 4: 451-464
103. Lampe KJ, Antaris AL, Heilshorn SC (2013). Design of three-dimensional engineered protein hydrogels for tailored control of neurite growth. Acta Biomaterialia 9: 5590-5599
104. Lassmann H, van Horssen J, Mahad D (2012). Progressive multiple sclerosis: Pathology and pathogenesis. Nat Rev Neurol 8: 647-656
105. Lavik EB, Klassen H, Warfvinge K, Langer R, Young MJ (2005). Fabrication of degradable polymer scaffolds to direct the integration and differentiation of retinal progenitors. Biomaterials 26: 3187-3196
106. Lee H, McKeon RJ, Bellamkonda RV (2010). Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury. Proc Natl Acad Sci USA 107: 3340-3345
107. Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM (2000). VEGF gene delivery to myocardium: Deleterious effects of unregulated expression. Circulation 102: 898-901
108. Leipzig ND, Shoichet MS (2009). The effect of substrate stiffness on adult neural stem cell behavior. Biomaterials 30: 6867-6878
109. Leipzig ND, Xu CC, Zahir T, Shoichet MS (2010). Functional immobilization of interferon-gamma induces neuronal differentiation of neural stem cells. J Biomed Mater Res A 93A: 625-633
110. Lerou PH, Daley GQ (2005). Therapeutic potential of embryonic stem cells. Blood Rev 19: 321-331
111. Levesque SG, Shoichet MS (2006). Synthesis of cell-Adhesive dextran hydrogels and macroporous scaffolds. Biomaterials 27: 5277-5285
112. Lewis GP, Fisher SK (2003). Up-regulation of glial fibrillary acidic protein in response to retinal injury: Its potential role in glial remodeling and a comparison to vimentin expression. Int Rev Cytol 230: 263.
113. Li LX, Turner JE (1988). Inherited retinal dystrophy in the rcs rat-prevention of photoreceptor degeneration by pigment epithelial-cell transplantation. Exp Eye Res 47: 911-917
114. Li X, Liu X, Cui L, Brunson C, Zhao W, Bhat NR et al. (2013). Engineering an in situ crosslinkable hydrogel for enhanced remyelination. FASEB J 27: 1127-1136
115. Li Y, Raisman G (1994). Schwann-cells induce sprouting in motor and sensory axons in the adult-rat spinal-cord. J Neurosci 14: 4050-4063
116. Liebscher T, Schnell L, Schnell D, Scholl J, Schneider R, Gullo M et al. (2005). Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann Neurol 58: 706-719
117. Lietz M, Dreesmann L, Hoss M, Oberhoffner S, Schlosshauer B (2006). Neuro tissue engineering of glial nerve guides and the impact of different cell types. Biomaterials 27: 1425-1436
118. Liu BP, Fournier A, GrandPre T, Strittmatter SM (2002). Myelin-Associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science 297: 1190-1193
119. Liu SQ, Tian QA, Hedrick JL, Hui JHP, Ee PLR, Yang YY (2010). Biomimetic hydrogels for chondrogenic differentiation of human mesenchymal stem cells to neocartilage. Biomaterials 31: 7298-7307
120. Liu Z, Gao X, Kang T, Jiang M, Miao D, Gu G et al. (2013a). B6 Peptide-modified PEG-PLA nanoparticles for enhanced brain delivery of neuroprotective peptide. Bioconjug Chem 24: 997-1007
121. Liu ZY, Jiang MY, Kang T, Miao DY, Gu GZ, Song QX et al. (2013b). Lactoferrinmodified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration. Biomaterials 34: 3870-3881
122. Lo AC, Woo TT, Wong RL, Wong D (2011). Apoptosis and other cell death mechanisms after retinal detachment: Implications for photoreceptor rescue. Ophthalmologica 226(Suppl 1): 10-17
123. Lo EH, Dalkara T, Moskowitz MA (2003). Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4: 399-415
124. MacLaren RE, Pearson RA, MacNeil A, Douglas RH, Salt TE, Akimoto M et al. (2006). Retinal repair by transplantation of photoreceptor precursors. Nature 444: 203-207
125. MacLellan CL, Keough MB, Granter-Button S, Chernenko GA, Butt S, Corbett D (2011). A critical threshold of rehabilitation involving brain-derived neurotrophic factor is required for poststroke recovery. Neurorehabil Neural Repair 25: 740-748
126. Maheshwari G, Brown G, Lauffenburger DA, Wells A, Griffith LG (2000). Cell adhesion and motility depend on nanoscale RGD clustering. J Cell Sci 113(Pt 10): 1677-1686
127. Mardilovich A, Craig JA, McCammon MQ, Garg A, Kokkoli E (2006). Design of a novel fibronectin-mimetic peptide-Amphiphile for functionalized biomaterials. Langmuir 22: 3259-3264
128. Martino MM, Tortelli F, Mochizuki M, Traub S, Ben-David D, Kuhn GA et al. (2011). Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci Translation Med 3: 100
129. Massia SP, Hubbell JA (1991). An RGD spacing of 440 nm is sufficient for integrin alpha V beta 3-mediated fibroblast spreading and 140 nm for focal contact and stress fiber formation. J Cell Biol 114: 1089-1100
130. Matsuse D, Kitada M, Ogura F, Wakao S, Kohama M, Kira J et al. (2011). Combined transplantation of bone marrow stromal cell-derived neural progenitor cells with a collagen sponge and basic fibroblast growth factor releasing microspheres enhances recovery after cerebral ischemia in rats. Tissue Eng A 17: 1993-2004
131. McCulloch EA, Till JE (2005). Perspectives on the properties of stem cells. Nat Med 11: 1026-1028
132. McDonald JW, Liu XZ, Qu Y, Liu S, Mickey SK, Turetsky D et al. (1999). Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 5: 1410-1412
133. Menon PK, Muresanu DF, Sharma A, Mossler H, Sharma HS (2012). Cerebrolysin, a mixture of neurotrophic factors induces marked neuroprotection in spinal cord injury following intoxication of engineered nanoparticles from metals. CNS Neurol Disord Drug Targets 11: 40-49
134. Milne JJ (2011). Scale-up of protein purification: Downstream processing issues. In: Walls D, Loughran ST (eds) Protein Chromatography: Methods and Protocols. Springer Science Business Media: Hatfield, pp 73-85
135. Mo XM, Xu CY, Kotaki M, Ramakrishna S (2004). Electrospun P(LLA-CL) nanofiber: A biomimetic extracellular matrix for smooth muscle cell and endothelial cell proliferation. Biomaterials 25: 1883-1890
136. Moon LD, Asher RA, Fawcett JW (2003). Limited growth of severed CNS axons after treatment of adult rat brain with hyaluronidase. J Neurosci Res 71: 23-37
137. Moore MJ, Friedman JA, Lewellyn EB, Mantila SM, Krych AJ, Ameenuddin S et al. (2006). Multiple-channel scaffolds to promote spinal cord axon regeneration. Biomaterials 27: 419-429
138. Mothe AJ, Tam RY, Zahir T, Tator CH, Shoichet MS (2013). Repair of the injured spinal cord by transplantation of neural stem cells in a hyaluronan-based hydrogel. Biomaterials 34: 3775-3783
139. Musah S, Morin SA, Wrighton PJ, Zwick DB, Jin S, Kiessling LL (2012). Glycosaminoglycan-binding hydrogels enable mechanical control of human pluripotent stem cell self-renewal. ACS Nano 6: 10168-10177
140. Nakaguchi K, Jinnou H, Kaneko N, Sawada M, Hikita T, Saitoh S et al. (2012). Growth factors released from gelatin hydrogel microspheres increase new neurons in the adult mouse brain. Stem Cells Int 2012: 915160
141. Neiiendam JL, Kohler LB, Christensen C, Li SZ, Pedersen MV, Ditlevsen DK et al. (2004). An NCAM-derived FGF-receptor agonist, the FGL-peptide, induces neurite outgrowth and neuronal survival in primary rat neurons. J Neurochem 91: 920-935
142. Nistor GI, Totoiu MO, Haque N, Carpenter MK, Keirstead HS (2005). Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 49: 385-396
143. Nowak JZ (2006). Age-related macular degeneration (AMD): Pathogenesis and therapy. Pharmacol Rep 58: 353-363
144. Ohab JJ, Fleming S, Blesch A, Carmichael ST (2006). A neurovascular niche for neurogenesis after stroke. J Neurosci 26: 13007-13016
145. Orive G, Anitua E, Pedraz JL, Emerich DF (2009). Biomaterials for promoting brain protection, repair and regeneration. Nat Rev Neurosci 10: 682-U647
146. Owen SC, Fisher SA, Tam RY, Nimmo CM, Shoichet MS (2013). Hyaluronic acid click hydrogels emulate the extracellular matrix. Langmuir 29: 7393-7400
147. Owen SC, Shoichet MS (2010). Design of three-dimensional biomimetic scaffolds. J Biomed Mater Res A 94A: 1321-1331
148. Pakulska MM, Ballios BG, Shoichet MS (2012). Injectable hydrogels for central nervous system therapy. Biomed Mater 7: 024101
149. Pakulska MM, Vulic K, Shoichet MS (2013). Affinity-based release of Chondroitinase ABC from a modified methylcellulose hydrogel. J Control Release 171: 11-16
150. Pardridge WM (2012). Drug transport across the blood-brain barrier. J Cerebr Blood F Met 32: 1959-1972
151. Park KI, Teng YD, Snyder EY (2002). The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat Biotechnol 20: 1111-1117
152. Pastor JC, de la Rua ER, Martin F (2002). Proliferative vitreoretinopathy: Risk factors and pathobiology. Prog Retinal Eye Res 21: 127-144
153. Patel MM, Goyal BR, Bhadada SV, Bhatt JS, Amin AF (2009). Getting into the brain: Approaches to enhance brain drug delivery. CNS Drugs 23: 35-58
154. Perale G, Rossi F, Santoro M, Peviani M, Papa S, Llupi D et al. (2012). Multiple drug delivery hydrogel system for spinal cord injury repair strategies. J Control Release 159: 271-280
155. Pettikiriarachchi JTS, Parish CL, Shoichet MS, Forsythe JS, Nisbet DR (2010). Biomaterials for brain tissue engineering. Aust J Chem 63: 1143-1154
156. Pfeifer K, Vroemen M, Caioni M, Aigner L, Bogdahn U, Weidner N (2006). Autologous adult rodent neural progenitor cell transplantation represents a feasible strategy to promote structural repair in the chronically injured spinal cord. Regen Med 1: 255-266
157. Piantino J, Burdick JA, Goldberg D, Langer R, Benowitz LI (2006). An injectable, biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and improves performance after spinal cord injury. Exp Neurol 201: 359-367
158. Pierschbacher MD, Ruoslahti E (1984). Cell Attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309: 30-33
159. Popa-Wagner A, Stocker K, Balseanu AT, Rogalewski A, Diederich K, Minnerup J et al. (2010). Effects of granulocyte-colony stimulating factor after stroke in aged rats. Stroke 41: 1027-1031
160. Prowse ABJ, Chong F, Gray PP, Munro TP (2011). Stem cell integrins: Implications for ex-vivo culture and cellular therapies. Stem Cell Res 6: 1-12
161. Quertainmont R, Cantinieaux D, Botman O, Sid S, Schoenen J, Franzen R (2012). Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-Angiogenic actions. PLoS One 7: E39500
162. Rajnicek AM, Britland S, McCaig CD (1997). Contact guidance of CNS neurites on grooved quartz: Influence of groove dimensions, neuronal age and cell type. J Cell Sci 110: 2905-2913
163. Ramon-Cueto A, Plant GW, Avila J, Bunge MB (1998). Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J Neurosci 18: 3803-3815
164. Ranjan AP, Mukerjee A, Helson L, Vishwanatha JK (2012). Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy. J Nanobiotechnol 10: 38
165. Rapalino O, Lazarov-Spiegler O, Agranov E, Velan GJ, Yoles E, Fraidakis M et al. (1998). Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med 4: 814-821
166. Redenti S, Neeley WL, Rompani S, Saigal S, Yang J, Klassen H et al. (2009). Engineering retinal progenitor cell and scrollable poly(glycerol- sebacate) composites for expansion and subretinal transplantation. Biomaterials 30: 3405-3414
167. Reynolds BA, Weiss S (1992). Generation of neurons and astrocytes from isolated cells of the adult mammalian central-nervous-system. Science 255: 1707-1710
168. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H et al. (1994). Bacterial endotoxin: Molecular relationships of structure to activity and function. FASEB J 8: 217-225
169. Rossi F, Perale G, Papa S, Forloni G, Veglianese P (2013). Current options for drug delivery to the spinal cord. Expert Opin Drug Deliv 10: 385-396
170. Rowe NA, Biswas S, Lloyd IC (2004). Primary IOL implantation in children: A risk analysis of foldable acrylic vs PMMA lenses. Br J Ophthalmol 88: 481-485
171. Roy D, Cambre JN, Sumerlin BS (2010). Future perspectives and recent advances in stimuli-responsive materials. Prog Polym Sci 35: 278-301
172. Royo PE, Quay WB (1959). Retinal transplantation from fetal to maternal mammalian eye. Growth 23: 313-336
173. Schabitz WR, Steigleder T, Cooper-Kuhn CM, Schwab S, Sommer C, Schneider A et al. (2007). Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke 38: 2165-2172
174. Schnell E, Klinkhammer K, Balzer S, Brook G, Klee D, Dalton P et al. (2007). Guidance of glial cell migration and axonal growth on electrospun nanofibers of poly-epsilon-caprolactone and a collagen/poly-epsilon-caprolactone blend. Biomaterials 28: 3012-3025
175. Schwab ME, Bartholdi D (1996). Degeneration and regeneration of axons in the lesioned spinal cord. Physiol Rev 76: 319-370
176. Seiler MJ, Aramant RB (1998). Intact sheets of fetal retina transplanted to restore damaged rat retinas. Invest Ophth Vis Sci 39: 2121-2131
177. Seiler MJ, Aramant RB (2012). Cell replacement and visual restoration by retinal sheet transplants. Prog Retin Eye Res 31: 661-687
178. Sekhon LHS, Fehlings MG (2001). Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 26: S2-S12
179. Shintani K, Shechtman DL, Gurwood AS (2009). Review and update: Current treatment trends for patients with retinitis pigmentosa. Optometry 80: 384-401
180. Shoichet MS, Tate CC, Baumann MD, LaPlaca MC (2008). Strategies for Regeneration and Repair in the Injured Central Nervous System. In WM R (ed) Indwelling Neural Implants: Strategies for Contending with the In Vivo Environment. CRC Press: Boca Raton, FL, USA
181. Silva NA, Cooke MJ, Tam RY, Sousa N, Salgado AJ, Reis RL et al. (2012). The effects of peptide modified gellan gum and olfactory ensheathing glia cells on neural stem/progenitor cell fate. Biomaterials 33: 6345-6354
182. Siminovitch L, McCulloch EA, Till JE (1963). The distribution of colony-forming cells among spleen colonies. J Cell Physiol 62: 327-336
183. Singhvi R, Kumar A, Lopez GP, Stephanopoulos GN, Wang DI, Whitesides GM et al. (1994). Engineering cell shape and function. Science 264: 696-698
184. Smeal RM, Rabbitt R, Biran R, Tresco PA (2005). Substrate curvature influences the direction of nerve outgrowth. Ann Biomed Eng 33: 376-382
185. Smeal RM, Tresco PA (2008). The influence of substrate curvature on neurite outgrowth is cell type dependent. Exp Neurol 213: 281-292
186. Snyder EY, Park KI (2002). Limitations in brain repair. Nat Med 8: 928-930
187. Su J, Hu BH, Lowe WL Jr., Kaufman DB, Messersmith PB (2010). Anti-inflammatory peptide-functionalized hydrogels for insulin-secreting cell encapsulation. Biomaterials 31: 308-314
188. Sun T, Mai S, Norton D, Haycock JW, Ryan AJ, MacNeil S (2005). Self-organization of skin cells in three-dimensional electrospun polystyrene scaffolds. Tissue Eng 11: 1023-1033
189. Sun YJ, Jin KL, Xie L, Childs J, Mao XO, Logvinova A et al. (2003). VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 111: 1843-1851
190. Sur S, Newcomb CJ, Webber MJ, Stupp SI (2013). Tuning supramolecular mechanics to guide neuron development. Biomaterials 34: 4749-4757
191. Suzuki M, Raisman G (1992). The glial framework of central white matter tracts: Segmented rows of contiguous interfascicular oligodendrocytes and solitary astrocytes give rise to a continuous meshwork of transverse and longitudinal processes in the adult rat fimbria. Glia 6: 222-235
192. Taddei ML, Giannoni E, Fiaschi T, Chiarugi P (2012). Anoikis: An emerging hallmark in health and diseases. J Pathol 226: 380-393
193. Takahashi K, Yamanaka S (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676
194. Takenaga M, Ishihara T, Ohta Y, Tokura Y, Hamaguchi A, Igarashi R et al. (2010). Nano PGE1 promoted the recovery from spinal cord injury-induced motor dysfunction through its accumulation and sustained release. J Control Release 148: 249-254
195. Tam RY, Cooke MJ, Shoichet MS (2012). A covalently modified hydrogel blend of hyaluronan-methyl cellulose with peptides and growth factors influences neural stem/progenitor cell fate. J Mater Chem 22: 19402-19411
196. Tao S, Young C, Redenti S, Zhang YQ, Klassen H, Desai T et al. (2007). Survival, migration and differentiation of retinal progenitor cells transplanted on micromachined poly(methyl methacrylate) scaffolds to the subretinal space. Lab Chip 7: 695-701
197. Tashiro K, Sephel GC, Weeks B, Sasaki M, Martin GR, Kleinman HK et al. (1989). A synthetic peptide containing the ikvav sequence from the a-chain of laminin mediates cell attachment, migration, and neurite outgrowth. J Biol Chem 264: 16174-16182
198. Taylor SJ, Rosenzweig ES, McDonald JW, Sakiyama-Elbert SE (2006). Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury. J Control Release 113: 226-235
199. Teramoto T, Qu JH, Plumier JC, Moskowitz MA (2003). EGF amplifies the replacement of parvalbumin-expressing striatal interneurons after ischemia. J Clin Invest 111: 1125-1132
200. Tester NJ, Plaas AH, Howland DR (2007). Effect of body temperature on chondroitinase ABC's ability to cleave chondroitin sulfate glycosaminoglycans. J Neurosci Res 85: 1110-1118
201. Tibbitt MW, Anseth KS (2009). Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng 103: 655-663
202. Till JE, McCulloch EA (1961). A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 14: 213-222
203. Tognetto D, Toto L, Minutola D, Ballone E, Di Nicola M, Di Mascio R et al. (2003). Hydrophobic acrylic versus heparin surface-modified polymethylmethacrylate intraocular lens: A biocompatibility study. Graefes Arch Clin Exp Ophthalmol 241: 625-630
204. Tomita M, Lavik E, Klassen H, Zahir T, Langer R, Young MJ (2005a). Biodegradable polymer composite grafts promote the survival and differentiation of retinal progenitor cells. Stem Cells 23: 1579-1588
205. Tonge DA, de Burgh HT, Docherty R, Humphries MJ, Craig SE, Pizzey J (2012). Fibronectin supports neurite outgrowth and axonal regeneration of adult brain neurons in vitro. Brain Res 1453: 8-16
206. Tropepe V, Coles BL, Chiasson BJ, Horsford DJ, Elia AJ, McInnes RR et al. (2000). Retinal stem cells in the adult mammalian eye. Science 287: 2032-2036
207. Tsai EC, Dalton PD, Shoichet MS, Tator CH (2004). Synthetic hydrogel guidance channels facilitate regeneration of adult rat brainstem motor axons after complete spinal cord transection. J Neurotrauma 21: 789-804
208. Tsuji O, Miura K, Okada Y, Fujiyoshi K, Mukaino M, Nagoshi N et al. (2010). Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci USA 107: 12704-12709
209. Tucker BA, Redenti SM, Jiang CH, Swift JS, Klassen HJ, Smith ME et al. (2010). The use of progenitor cell/biodegradable MMP2-PLGA polymer constructs to enhance cellular integration and retinal repopulation. Biomaterials 31: 9-19
210. Tureyen K, Vemuganti R, Bowen KK, Sailor KA, Dempsey RJ (2005). EGF and FGF-2 infusion increases post-ischemic neural progenitor cell proliferation in the adult rat brain. Neurosurgery 57: 1254-1262
211. Turner JE, Seiler M, Aramant R, Blair JR (1988). Embryonic retinal grafts transplanted into the lesioned adult rat retina. Prog Brain Res 78: 131-139
212. Tysseling-Mattiace VM, Sahni V, Niece KL, Birch D, Czeisler C, Fehlings MG et al. (2008). Self-Assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury. J Neurosci 28: 3814-3823
213. Victorio SCS, Havton LA, Oliveira ALR (2010). Absence of IFN gamma expression induces neuronal degeneration in the spinal cord of adult mice. J Neuroinflamm 7: 77-90
214. Volpato FZ, Fuhrmann T, Migliaresi C, Hutmacher DW, Dalton PD (2013). Using extracellular matrix for regenerative medicine in the spinal cord. Biomaterials 34: 4945-4955
215. Vulic K, Shoichet MS (2012). Tunable growth factor delivery from injectable hydrogels for tissue engineering. J Am Chem Soc 134: 882-885
216. Wamil AW, Wamil BD, Hellerqvist CG (1998). CM101-mediated recovery of walking ability in adult mice paralyzed by spinal cord injury. Proc Natl Acad Sci USA 95: 13188-13193
217. Wang TY, Forsythe JS, Nisbet DR, Parish CL (2012a). Promoting engraftment of transplanted neural stem cells/progenitors using biofunctionalised electrospun scaffolds. Biomaterials 33: 9188-9197
218. Wang YF, Cooke MJ, Morshead CM, Shoichet MS (2012b). Hydrogel delivery of erythropoietin to the brain for endogenous stem cell stimulation after stroke injury. Biomaterials 33: 2681-2692
219. Wechsler LR (2009). Clinical trials of stroke therapy which cells, which patients? Stroke 40: S149-S151
220. Wei YT, He Y, Xu CL, Wang Y, Liu BF, Wang XM et al. (2010). Hyaluronic acid hydrogel modified with nogo-66 receptor antibody and poly-L-lysine to promote axon regrowth after spinal cord injury. J Biomed Mater Res B Appl Biomater 95: 110-117
221. Weiss S, Dunne C, Hewson J, Wohl C, Wheatley M, Peterson AC et al. (1996). Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J Neurosci 16: 7599-7609
222. Wenkel H, Streilein JW (2000). Evidence that retinal pigment epithelium functions as an immune-privileged tissue. Invest Ophth Vis Sci 41: 3467-3473
223. Werner C, Engelhard K (2007). Pathophysiology of traumatic brain injury. Br J Anaesth 99: 4-9
224. West EL, Pearson RA, Tschernutter M, Sowden JC, MacLaren RE, Ali RR (2008). Pharmacological disruption of the outer limiting membrane leads to increased retinal integration of transplanted photoreceptor precursors. Exp Eye Res 86: 601-611
225. White RE, Jakeman LB (2008). Don't fence me in: Harnessing the beneficial roles of astrocytes for spinal cord repair. Restor Neurol Neurosci 26: 197-214
226. Willerth SM (2011). Neural tissue engineering using embryonic and induced pluripotent stem cells. Stem Cell Res Ther 2: 17
227. Wongpichedchai S, Weiter JJ, Weber P, Dorey CK (1992). Comparison of external and internal approaches for transplantation of autologous retinal pigment epithelium. Invest Ophthalmol Vis Sci 33: 3341-3352
228. Wosnick JH, Shoichet MS (2008). Three-dimensional chemical patterning of transparent hydrogels. Chem Mater 20: 55-60
229. Wright LS, Li J, Caldwell MA, Wallace K, Johnson JA, Svendsen CN (2003). Gene expression in human neural stem cells: Effects of leukemia inhibitory factor. J Neurochem 86: 179-195
230. Wylie RG, Ahsan S, Aizawa Y, Maxwell KL, Morshead CM, Shoichet MS (2011). Spatially controlled simultaneous patterning of multiple growth factors in threedimensional hydrogels. Nat Mater 10: 799-806
231. Yamanaka A, Nakamae K, Takeuchi M, Momose A, Fukado Y, Oshima K et al. (1985). Scanning electron microscope study on the biodegradation of IOL and suturing materials. Trans Ophthalmol Soc UK 104(Pt 5): 517-521
232. Yandava BD, Billinghurst LL, Snyder EY (1999). 'Global' cell replacement is feasible via neural stem cell transplantation: Evidence from the dysmyelinated shiverer mouse brain. Proc Natl Acad Sci USA 96: 7029-7034
233. Zhan X, Gao M, Jiang Y, Zhang W, Wong WM, Yuan Q et al. (2013). Nanofiber scaffolds facilitate functional regeneration of peripheral nerve injury. Nanomed Nanotechnol Biol Med 9: 305-315
234. Zhang HZ, Hayashi T, Tsuru K, Deguchi K, Nagdhara M, Hayakawa S et al. (2007a). Vascular endothelial growth factor promotes brain tissue regeneration with a novel biomaterial polydimethylsiloxane-Tetraethoxysilane. Brain Res 1132: 29-35
235. Zhang LQ, Ma ZW, Smith GM, Wen XJ, Pressman Y, Wood PM et al. (2009). GDNFenhanced axonal regeneration and myelination following spinal cord injury is mediated by primary effects on neurons. Glia 57: 1178-1191
236. Zhang Y, Klassen HJ, Tucker BA, Perez MTR, Young MJ (2007b). CNS progenitor cells promote a permissive environment for neurite outgrowth via a matrix metalloproteinase-2-dependent mechanism. J Neurosci 27: 4499-4506
237. Zhong J, Chan A, Morad L, Kornblum HI, Fan GP, Carmichael ST (2010). Hydrogel matrix to support stem cell survival after brain transplantation in stroke. Neurorehab Neural Re 24: 636-644
238. Zhu J, Marchant RE (2011). Design properties of hydrogel tissue-engineering scaffolds. Expert Rev Med Devices 8: 607-626
239. Zimmermann DR, Dours-Zimmermann MT (2008). Extracellular matrix of the central nervous system: From neglect to challenge. Histochem Cell Biol 130: 635-653
240. Zuo J, Neubauer D, Dyess K, Ferguson TA, Muir D (1998). Degradation of chondroitin sulfate proteoglycan enhances the neurite-promoting potential of spinal cord tissue. Exp Neurol 154: 654-662